
UCSF Researcher Honored for Cancer Drug Breakthrough
A new FDA-approved therapy for KRAS-mutated pancreatic cancer has doubled survival times in clinical trials.
Live Poll
Is the progress in cancer treatment making effective care more accessible for the average person?